AuroMedics Pharma LLC Issues Voluntary Nationwide Recall of Polymyxin B for Injection USP, 500,000 Unit per Vial, Due to the Presence of Particulate Matter

Date:  01/28/2022

Product type: Drugs, Potential Foreign Material

Company Announcement Date: January 26, 2022
FDA Publish Date: January 28, 2022
Product Type: Drugs
Reason for Announcement: Presence of Particulate Matter
Company Name: AuroMedics Pharma LLC
Brand Name: Auromedics
Product Description: Polymyxin B for Injection USP, 500,000 Units/Vial

USA-FDA Link:  https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/auromedics-pharma-llc-issues-voluntary-nationwide-recall-polymyxin-b-injection-usp-500000-unit-vial